DanCann Pharma, a biopharmaceutical company developing new therapeutic cannabinoids, has decided on a new share issue of up to 2,031,250 shares at a subscription price of DKK0.63 (US$0.09) per share…
DanCann Pharma, a biopharmaceutical company developing new therapeutic cannabinoids, has decided on a new share issue of up to 2,031,250 shares at a subscription price of DKK0.63 (US$0.09) per share…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference